TWEAK/Fn14 axis in respiratory diseases.

[1]  J. Raj,et al.  Pathobiology of Pulmonary Artery Hypertension: Role of lncRNAs. , 2020, Cardiovascular research.

[2]  Sathya D. Unudurthi,et al.  Fibroblast growth factor-inducible 14 mediates macrophage infiltration in heart to promote pressure overload-induced cardiac dysfunction. , 2020, Life sciences.

[3]  J. Cuesta-Herranz,et al.  The TNF-like weak inducer of the apoptosis/fibroblast growth factor-inducible molecule 14 axis mediates histamine and platelet-activating factor-induced subcutaneous vascular leakage and anaphylactic shock. , 2020, The Journal of allergy and clinical immunology.

[4]  Zhuying Li,et al.  Icariside II attenuates eosinophils-induced airway inflammation and remodeling via inactivation of NF-κB and STAT3 in an asthma mouse model. , 2020, Experimental and molecular pathology.

[5]  H. Siragy,et al.  Pro-renin receptor suppresses mitochondrial biogenesis and function via AMPK/SIRT-1/ PGC-1α pathway in diabetic kidney , 2019, PloS one.

[6]  Y. Choi,et al.  Cryptotanshinone Attenuates Airway Remodeling by Inhibiting Crosstalk Between Tumor Necrosis Factor-Like Weak Inducer of Apoptosis and Transforming Growth Factor Beta 1 Signaling Pathways in Asthma , 2019, Front. Pharmacol..

[7]  Yu-yu Yao,et al.  TWEAK promotes endothelial progenitor cell vasculogenesis to alleviate acute myocardial infarction via the Fn14-NF-κB signaling pathway , 2018, Experimental and therapeutic medicine.

[8]  Fei Xie,et al.  TWEAK/Fn14 mediates atrial‐derived HL‐1 myocytes hypertrophy via JAK2/STAT3 signalling pathway , 2018, Journal of cellular and molecular medicine.

[9]  Yan Lu,et al.  Obstructive Sleep Apnea Syndrome and Metabolic Diseases , 2018, Endocrinology.

[10]  T. Luedde,et al.  Differential Roles of Tumor Necrosis Factor Ligand Superfamily Members as Biomarkers in Pancreatic Cancer , 2018, Journal of Clinical Medicine.

[11]  Leguo Zhang,et al.  TWEAK/Fn14 interaction induces proliferation and migration in human airway smooth muscle cells via activating the NF‐κB pathway , 2018, Journal of cellular biochemistry.

[12]  Chaoyang Wang,et al.  Src Promotes Metastasis of Human Non-Small Cell Lung Cancer Cells through Fn14-Mediated NF-κB Signaling , 2018, Medical science monitor : international medical journal of experimental and clinical research.

[13]  F. Sun,et al.  Involvement of TWEAK and the NF-κB signaling pathway in lupus nephritis. , 2018, Experimental and therapeutic medicine.

[14]  K. Kim,et al.  Sputum TWEAK expression correlates with severity and degree of control in non‐eosinophilic childhood asthma , 2018, Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology.

[15]  J. Mialet-Perez,et al.  Autophagy in health and disease: focus on the cardiovascular system. , 2017, Essays in biochemistry.

[16]  J. Hung,et al.  Investigation of the role of tumor necrosis factor-like weak inducer of apoptosis in non-small cell lung cancer. , 2017, Oncology reports.

[17]  K. Kowal,et al.  The significance of diminished sTWEAK and P‐selectin content in platelets of patients with pulmonary arterial hypertension , 2017, Cytokine.

[18]  Wei Chen,et al.  TWEAK/Fn14 promotes oxidative stress through AMPK/PGC‑1α/MnSOD signaling pathway in endothelial cells. , 2017, Molecular medicine reports.

[19]  Junjuan Lu,et al.  Tumor necrosis factor-like weak inducer of apoptosis regulates quadriceps muscle atrophy and fiber-type alteration in a rat model of chronic obstructive pulmonary disease , 2017, Tobacco induced diseases.

[20]  Jingjing Tang,et al.  Curcumin attenuates skeletal muscle mitochondrial impairment in COPD rats: PGC-1α/SIRT3 pathway involved. , 2017, Chemico-biological interactions.

[21]  C. Henke,et al.  IL-8 mediates idiopathic pulmonary fibrosis mesenchymal progenitor cell fibrogenicity , 2017, American journal of physiology. Lung cellular and molecular physiology.

[22]  M. Moreno-Aliaga,et al.  Role of Omentin, Vaspin, Cardiotrophin-1, TWEAK and NOV/CCN3 in Obesity and Diabetes Development , 2017, International journal of molecular sciences.

[23]  Yuanyuan Xu,et al.  TWEAK/Fn14 promotes pro‐inflammatory cytokine secretion in hepatic stellate cells via NF‐&kgr;B/STAT3 pathways , 2017, Molecular immunology.

[24]  Yumin Xia,et al.  TWEAK/Fn14 signaling in tumors , 2017, Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine.

[25]  Dong Li,et al.  TWEAK-stimulated macrophages inhibit metastasis of epithelial ovarian cancer via exosomal shuttling of microRNA. , 2017, Cancer letters.

[26]  F. Wang,et al.  FN14 Blockade on Pulmonary Microvascular Endothelial Cells Improves the Outcome of Sepsis-Induced Acute Lung Injury , 2017, Shock.

[27]  A. Ortiz,et al.  Tweak up-regulates endothelin-1 system in mouse and human endothelial cells , 2017, Cardiovascular research.

[28]  P. Codogno,et al.  Autophagy: A Druggable Process. , 2017, Annual review of pharmacology and toxicology.

[29]  D. Tweardy,et al.  STAT3 inhibition prevents lung inflammation, remodeling, and accumulation of Th2 and Th17 cells in a murine asthma model , 2016, Allergy.

[30]  S. Qin,et al.  Anti‐TWEAK monoclonal antibodies reduce vascular damage and leucocyte infiltration in a mouse model of cutaneous reverse passive Arthus reaction , 2016, Clinical and experimental dermatology.

[31]  J. Pépin,et al.  Targeting the ROS-HIF-1-endothelin axis as a therapeutic approach for the treatment of obstructive sleep apnea-related cardiovascular complications. , 2016, Pharmacology & therapeutics.

[32]  J. Winkles,et al.  TWEAK activation of the non-canonical NF-κB signaling pathway differentially regulates melanoma and prostate cancer cell invasion , 2016, Oncotarget.

[33]  Jian Guo,et al.  TWEAK protects cardiomyocyte against apoptosis in a PI3K/AKT pathway dependent manner. , 2016, American journal of translational research.

[34]  C. Putterman,et al.  Intracerebroventricular administration of TNF-like weak inducer of apoptosis induces depression-like behavior and cognitive dysfunction in non-autoimmune mice , 2016, Brain, Behavior, and Immunity.

[35]  M. Schwaninger,et al.  The role of TWEAK/Fn14 signaling in the MPTP-model of Parkinson’s disease , 2016, Neuroscience.

[36]  G. Su,et al.  Tumor necrosis factor-like weak inducer of apoptosis association with proliferative diabetic retinopathy and promotes proliferation and collagen synthesis in retinal ARPE-19 cells. , 2016, Genetics and molecular research : GMR.

[37]  Wenwei Zhang,et al.  Fn14, a Downstream Target of the TGF-β Signaling Pathway, Regulates Fibroblast Activation , 2015, PloS one.

[38]  M. Bowerman,et al.  Tweak regulates astrogliosis, microgliosis and skeletal muscle atrophy in a mouse model of amyotrophic lateral sclerosis. , 2015, Human molecular genetics.

[39]  M. Schwartz,et al.  TNF-like weak inducer of apoptosis promotes blood brain barrier disruption and increases neuronal cell death in MRL/lpr mice. , 2015, Journal of autoimmunity.

[40]  C. Putterman,et al.  Deficiency of fibroblast growth factor-inducible 14 (Fn14) preserves the filtration barrier and ameliorates lupus nephritis. , 2015, Journal of the American Society of Nephrology : JASN.

[41]  Kazuhisa Takahashi,et al.  TWEAK enhances TGF-β-induced epithelial-mesenchymal transition in human bronchial epithelial cells , 2015, Respiratory Research.

[42]  Ashok Kumar,et al.  Elevated levels of TWEAK in skeletal muscle promote visceral obesity, insulin resistance, and metabolic dysfunction , 2015, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[43]  Ji-Ung Jung,et al.  Tumor necrosis factor-like weak inducer of apoptosis (TWEAK) promotes glioma cell invasion through induction of NF-κB-inducing kinase (NIK) and noncanonical NF-κB signaling , 2015, Molecular Cancer.

[44]  Q. Hou,et al.  [Recent advances in the study of AMPK and inflammatory pulmonary disease]. , 2014, Yao xue xue bao = Acta pharmaceutica Sinica.

[45]  Wei Huang,et al.  Fn14 Promotes Differentiation of Human Mesenchymal Stem Cells into Heart Valvular Interstitial Cells by Phenotypic Characterization , 2014, Journal of cellular physiology.

[46]  T. J. Nickola,et al.  IL-1β induction of MUC5AC gene expression is mediated by CREB and NF-κB and repressed by dexamethasone. , 2014, American journal of physiology. Lung cellular and molecular physiology.

[47]  S. Bhatnagar,et al.  Regulatory circuitry of TWEAK‐Fn14 system and PGC‐1α in skeletal muscle atrophy program , 2014, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[48]  H. Katus,et al.  TNF-Like Weak Inducer of Apoptosis Aggravates Left Ventricular Dysfunction after Myocardial Infarction in Mice , 2014, Mediators of inflammation.

[49]  L. Burkly,et al.  Genetic deletion or TWEAK blocking antibody administration reduce atherosclerosis and enhance plaque stability in mice , 2014, Journal of cellular and molecular medicine.

[50]  M. Bittner,et al.  Mcl-1 Mediates TWEAK/Fn14-Induced Non–Small Cell Lung Cancer Survival and Therapeutic Response , 2014, Molecular Cancer Research.

[51]  R. Schermuly,et al.  TWEAK/Fn14 axis is a positive regulator of cardiac hypertrophy. , 2013, Cytokine.

[52]  F. Tinahones,et al.  The rise of soluble TWEAK levels in severely obese subjects after bariatric surgery may affect adipocyte-cytokine production induced by TNFα. , 2013, The Journal of clinical endocrinology and metabolism.

[53]  G. Semenza,et al.  Activation of hypoxia-inducible factor-1 in pulmonary arterial smooth muscle cells by endothelin-1. , 2013, American journal of physiology. Lung cellular and molecular physiology.

[54]  W. Di,et al.  Correction: Functional Expression of TWEAK and the Receptor Fn14 in Human Malignant Ovarian Tumors: Possible Implication for Ovarian Tumor Intervention , 2013, PLoS ONE.

[55]  L. Burkly,et al.  HMGB1 Expression and Secretion Are Increased Via TWEAK–Fn14 Interaction in Atherosclerotic Plaques and Cultured Monocytes , 2013, Arteriosclerosis, thrombosis, and vascular biology.

[56]  Mohit M. Jain,et al.  PGC1α Plays a Critical Role in TWEAK–Induced Cardiac Dysfunction , 2013, PloS one.

[57]  C. Putterman,et al.  TWEAK/Fn14 pathway modulates properties of a human microvascular endothelial cell model of blood brain barrier , 2013, Journal of Neuroinflammation.

[58]  J. Crim,et al.  Lower frequency of obstructive sleep apnea in spondyloarthritis patients taking TNF-inhibitors. , 2012, Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine.

[59]  C. Putterman,et al.  Inhibition of the TWEAK/Fn14 pathway attenuates renal disease in nephrotoxic serum nephritis. , 2012, Clinical immunology.

[60]  R. Schermuly,et al.  Deletion of Fn14 receptor protects from right heart fibrosis and dysfunction , 2012, Basic Research in Cardiology.

[61]  L. Burkly,et al.  The TWEAK/Fn14 pathway as an aggravating and perpetuating factor in inflammatory diseases; focus on inflammatory bowel diseases , 2012, Journal of leukocyte biology.

[62]  King-Jen Chang,et al.  Prognostic Significance of TWEAK Expression in Colorectal Cancer and Effect of Its Inhibition on Invasion , 2012, Annals of Surgical Oncology.

[63]  Huishan Chen,et al.  TWEAK/Fn14 promotes the proliferation and collagen synthesis of rat cardiac fibroblasts via the NF-кB pathway , 2012, Molecular Biology Reports.

[64]  S. Bhatnagar,et al.  TWEAK and TRAF6 regulate skeletal muscle atrophy , 2012, Current opinion in clinical nutrition and metabolic care.

[65]  Sanjay Kumar Gupta,et al.  TWEAK causes myotube atrophy through coordinated activation of ubiquitin‐proteasome system, autophagy, and caspases , 2012, Journal of cellular physiology.

[66]  S. Bhatnagar,et al.  The E3 Ubiquitin Ligase TRAF6 Intercedes in Starvation-Induced Skeletal Muscle Atrophy through Multiple Mechanisms , 2012, Molecular and Cellular Biology.

[67]  A. Choi,et al.  Autophagy: a core cellular process with emerging links to pulmonary disease. , 2011, American journal of respiratory and critical care medicine.

[68]  M. Sánchez-Niño,et al.  TWEAK, a multifunctional cytokine in kidney injury. , 2011, Kidney international.

[69]  A. Davies,et al.  Hypoxia-inducible factor-1 in arterial disease: a putative therapeutic target. , 2011, Current vascular pharmacology.

[70]  H. Katus,et al.  Soluble TWEAK predicts hemodynamic impairment and functional capacity in patients with pulmonary arterial hypertension , 2011, Clinical Research in Cardiology.

[71]  K. Shimada,et al.  Direct targeting of fibroblast growth factor-inducible 14 protein protects against renal ischemia reperfusion injury. , 2011, Kidney international.

[72]  S. Amin,et al.  FOXO3 encodes a carcinogen-activated transcription factor frequently deleted in early-stage lung adenocarcinoma. , 2010, Cancer research.

[73]  Ji-Eun Kim,et al.  Roles of protein kinase B/Akt in lung cancer. , 2010, Frontiers in bioscience.

[74]  F. Tinahones,et al.  Tumor necrosis-like weak inducer of apoptosis as a proinflammatory cytokine in human adipocyte cells: up-regulation in severe obesity is mediated by inflammation but not hypoxia. , 2010, The Journal of clinical endocrinology and metabolism.

[75]  M. Fujimoto,et al.  Elevated Circulating TWEAK Levels in Systemic Sclerosis: Association with Lower Frequency of Pulmonary Fibrosis , 2009, The Journal of Rheumatology.

[76]  M. Sánchez-Niño,et al.  Tweak induces proliferation in renal tubular epithelium: a role in uninephrectomy induced renal hyperplasia , 2009, Journal of cellular and molecular medicine.

[77]  Mohit M. Jain,et al.  A Novel Role for Tumor Necrosis Factor–Like Weak Inducer of Apoptosis (TWEAK) in the Development of Cardiac Dysfunction and Failure , 2009, Circulation.

[78]  P. Lévy,et al.  Major role for hypoxia inducible factor-1 and the endothelin system in promoting myocardial infarction and hypertension in an animal model of obstructive sleep apnea. , 2009, Journal of the American College of Cardiology.

[79]  S. Tyagi,et al.  Tumor Necrosis Factor-related Weak Inducer of Apoptosis Augments Matrix Metalloproteinase 9 (MMP-9) Production in Skeletal Muscle through the Activation of Nuclear Factor-κB-inducing Kinase and p38 Mitogen-activated Protein Kinase , 2009, Journal of Biological Chemistry.

[80]  R. Reynolds,et al.  Expression of TWEAK and Its Receptor Fn14 in the Multiple Sclerosis Brain: Implications for Inflammatory Tissue Injury , 2008, Journal of neuropathology and experimental neurology.

[81]  H. Cunliffe,et al.  The Fibroblast Growth Factor–Inducible 14 Receptor Is Highly Expressed in HER2-Positive Breast Tumors and Regulates Breast Cancer Cell Invasive Capacity , 2008, Molecular Cancer Research.

[82]  J. Winkles.  The TWEAK–Fn14 cytokine–receptor axis: discovery, biology and therapeutic targeting , 2008, Nature Reviews Drug Discovery.

[83]  M. Sánchez-Niño,et al.  The cytokine TWEAK modulates renal tubulointerstitial inflammation. , 2008, Journal of the American Society of Nephrology : JASN.

[84]  K. Okumura,et al.  Involvement of TWEAK/Fn14 interaction in the synovial inflammation of RA. , 2007, Rheumatology.

[85]  T. Zheng,et al.  TWEAKing tissue remodeling by a multifunctional cytokine: role of TWEAK/Fn14 pathway in health and disease. , 2007, Cytokine.

[86]  P. Schrauwen,et al.  Peroxisome proliferator-activated receptor expression is reduced in skeletal muscle in COPD , 2007, European Respiratory Journal.

[87]  C. Dogra,et al.  TNF‐related weak inducer of apoptosis (TWEAK) is a potent skeletal muscle‐wasting cytokine , 2007, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[88]  T. Kietzmann,et al.  Reactive Oxygen Species Activate the HIF-1&agr; Promoter Via a Functional NF&kgr;B Site , 2007 .

[89]  M. Diaz-Meco,et al.  Signal integration and diversification through the p62 scaffold protein. , 2007, Trends in biochemical sciences.

[90]  W. McNicholas,et al.  Predictors of elevated nuclear factor-kappaB-dependent genes in obstructive sleep apnea syndrome. , 2006, American journal of respiratory and critical care medicine.

[91]  E. Vichinsky,et al.  Pulmonary hypertension in thalassemia: Association with platelet activation and hypercoagulable state , 2006, American journal of hematology.

[92]  A. Nakao,et al.  TWEAK/Fn14 interaction regulates RANTES production, BMP-2-induced differentiation, and RANKL expression in mouse osteoblastic MC3T3-E1 cells , 2006, Arthritis research & therapy.

[93]  J. Fernández-Real,et al.  Expression of TWEAK and its receptor Fn14 in human subcutaneous adipose tissue. Relationship with other inflammatory cytokines in obesity. , 2006, Cytokine.

[94]  M. Yepes,et al.  Tumor Necrosis Factor-Like Weak Inducer of Apoptosis Increases the Permeability of the Neurovascular Unit through Nuclear Factor-κB Pathway Activation , 2005, The Journal of Neuroscience.

[95]  T. Zheng,et al.  Tweak induces mammary epithelial branching morphogenesis , 2005, Oncogene.

[96]  Z. Galis,et al.  Matrix metalloproteinase 9 facilitates collagen remodeling and angiogenesis for vascular constructs. , 2005, Tissue engineering.

[97]  G. Semenza,et al.  Ca2+/Calmodulin Kinase-dependent Activation of Hypoxia Inducible Factor 1 Transcriptional Activity in Cells Subjected to Intermittent Hypoxia* , 2005, Journal of Biological Chemistry.

[98]  D. Lawrence,et al.  A soluble Fn14-Fc decoy receptor reduces infarct volume in a murine model of cerebral ischemia. , 2005, The American journal of pathology.

[99]  K. Shiraki,et al.  Functional expression of TWEAK in human hepatocellular carcinoma: possible implication in cell proliferation and tumor angiogenesis. , 2004, Biochemical and biophysical research communications.

[100]  A. Nakao,et al.  TWEAK/Fn14 interaction stimulates human bronchial epithelial cells to produce IL-8 and GM-CSF. , 2004, Biochemical and biophysical research communications.

[101]  Wenfeng Xu,et al.  Cytokine–receptor pairing: accelerating discovery of cytokine function , 2004, Nature Reviews Drug Discovery.

[102]  Z. Galis,et al.  Matrix Metalloproteinase-2 and −9 Differentially Regulate Smooth Muscle Cell Migration and Cell-Mediated Collagen Organization , 2004, Arteriosclerosis, thrombosis, and vascular biology.

[103]  T. Saitoh,et al.  TWEAK Induces NF-κB2 p100 Processing and Long Lasting NF-κB Activation* , 2003, Journal of Biological Chemistry.

[104]  K. Okumura,et al.  Characterization of murine TWEAK and its receptor (Fn14) by monoclonal antibodies. , 2003, Biochemical and biophysical research communications.

[105]  J. Winkles,et al.  The Fn14 cytoplasmic tail binds tumour-necrosis-factor-receptor-associated factors 1, 2, 3 and 5 and mediates nuclear factor-kappaB activation. , 2003, The Biochemical journal.

[106]  T. Hla,et al.  TWEAK Is an Endothelial Cell Growth and Chemotactic Factor That Also Potentiates FGF-2 and VEGF-A Mitogenic Activity , 2003, Arteriosclerosis, thrombosis, and vascular biology.

[107]  H. Nakano,et al.  Pro-inflammatory effect of TWEAK/Fn14 interaction on human umbilical vein endothelial cells. , 2002, Biochemical and biophysical research communications.

[108]  M. Khrestchatisky,et al.  TWEAK is expressed by glial cells, induces astrocyte proliferation and increases EAE severity , 2002, Journal of Neuroimmunology.

[109]  M. López‐Fraga,et al.  An endogenous hybrid mRNA encodes TWE‐PRIL, a functional cell surface TWEAK–APRIL fusion protein , 2002, The EMBO journal.

[110]  E. Wang,et al.  Alterations in TNF‐ and IL‐related gene expression in space‐flown WI38 human fibroblasts , 2002, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[111]  C. Ambrose,et al.  Proinflammatory activity of TWEAK on human dermal fibroblasts and synoviocytes: blocking and enhancing effects of anti-TWEAK monoclonal antibodies , 2001, Arthritis research.

[112]  C. Smith,et al.  A novel TNF receptor family member binds TWEAK and is implicated in angiogenesis. , 2001, Immunity.

[113]  J. S. Hunt,et al.  Death-inducing tumour necrosis factor (TNF) superfamily ligands and receptors are transcribed in human placentae, cytotrophoblasts, placental macrophages and placental cell lines. , 2001, Placenta.

[114]  P. Dennis,et al.  Akt/protein kinase B is constitutively active in non-small cell lung cancer cells and promotes cellular survival and resistance to chemotherapy and radiation. , 2001, Cancer research.

[115]  R. Locksley,et al.  The TNF and TNF Receptor Superfamilies Integrating Mammalian Biology , 2001, Cell.

[116]  S. Moll,et al.  Down-regulated expression of TWEAK mRNA in acute and chronic inflammatory pathologies. , 2000, Biochemical and biophysical research communications.

[117]  J. Inoue,et al.  Tumor necrosis factor receptor-associated factor (TRAF) family: adapter proteins that mediate cytokine signaling. , 2000, Experimental cell research.

[118]  N. Copeland,et al.  The Mitogen-inducible Fn14 Gene Encodes a Type I Transmembrane Protein that Modulates Fibroblast Adhesion and Migration* , 1999, The Journal of Biological Chemistry.

[119]  M. Greenberg,et al.  Akt Promotes Cell Survival by Phosphorylating and Inhibiting a Forkhead Transcription Factor , 1999, Cell.

[120]  P. Scheurich,et al.  TNF receptor associated factors in cytokine signaling. , 1999, Cytokine & growth factor reviews.

[121]  J. Sheridan,et al.  Identification of a ligand for the death-domain-containing receptor Apo3 , 1998, Current Biology.

[122]  Y. Hsu,et al.  TWEAK, a New Secreted Ligand in the Tumor Necrosis Factor Family That Weakly Induces Apoptosis* , 1997, The Journal of Biological Chemistry.

[123]  M. Rabinovitch,et al.  Exogenous leukocyte and endogenous elastases can mediate mitogenic activity in pulmonary artery smooth muscle cells by release of extracellular matrix‐bound basic fibroblast growth factor , 1996, Journal of cellular physiology.

[124]  J. Egido,et al.  [Atorvastatin inhibits the atherosclerotic lesion induced by tumor necrosis factor-like weak inducer of apoptosis in apolipoprotein E deficient mice]. , 2015, Clinica e investigacion en arteriosclerosis : publicacion oficial de la Sociedad Espanola de Arteriosclerosis.

[125]  Harshil Dhruv,et al.  Tumor necrosis factor-like weak inducer of apoptosis (TWEAK) promotes glioblastoma cell chemotaxis via Lyn activation. , 2014, Carcinogenesis.

[126]  S. Matsumoto,et al.  Therapeutic potential of the TWEAK/Fn14 pathway in intractable gastrointestinal cancer. , 2011, Experimental and therapeutic medicine.

[127]  K. Shiraki,et al.  Functional expression of TWEAK in human colonic adenocarcinoma cells. , 2005, International journal of oncology.

[128]  M. Humbert,et al.  Inflammation in pulmonary arterial hypertension , 2003, European Respiratory Journal.